Bristol-Myers Squibb/BMY
US$44.03
-0.09%About Bristol-Myers Squibb
Ticker
Sector
Trading on
Industry
CEO
Employees
Headquarters
BMY Metrics
US$89B
-
-US$3.10
0.44
US$2.31
5.45%
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
What the Analysts think about BMY
Analyst Ratings
Price Targets
US$44.03
US$52.25
BMY Financial Performance
Income Statement
Q1 24
QoQ growth
US$12B
3.38%
-US$12B
-775.99%
-100.38%
-753.94%
BMY Earnings Performance
Earnings per share (EPS)
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
US$1.75
US$2.00
US$1.70
-US$4.40
-
US$1.98
US$1.76
US$1.53
-US$4.44
US$1.69
-11.43%
13.64%
11.13%
-0.8%
-
Upcoming events
FAQs
What’s the current market cap for Bristol-Myers Squibb stock?
What is the P/E ratio for Bristol-Myers Squibb stock?
Does Bristol-Myers Squibb stock pay dividends?
Yes, the Bristol-Myers Squibb (BMY) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $2.31 and the yield is 5.45%. Bristol-Myers Squibb has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Bristol-Myers Squibb dividend payment date?
The next Bristol-Myers Squibb (BMY) dividend payment date is unconfirmed.
What is the beta indicator for Bristol-Myers Squibb?
Bristol-Myers Squibb (BMY) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Bristol-Myers Squibb stock price target?
The target price for Bristol-Myers Squibb (BMY) stock is $52.25, which is 18.67% above the current price of $44.03. This is an average based on projections from 21 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.